Comparing Histone Deacetylase Inhibitor Responses in Genetically Engineered Mouse Lung Cancer Models and a Window of Opportunity Trial in Lung Cancer Patients

Histone deacetylase inhibitor (HDACi, vorinostat) responses were studied in murine and human lung cancer cell lines and genetically-engineered mouse lung cancer models. Findings were compared with a window of opportunity trial in aerodigestive tract cancers. In human (HOP62, H522 and H23) and murine...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Ma, Tian, Galimberti, Fabrizio, Erkmen, Cherie P., Memoli, Vincent, Chinyengetere, Fadzai, Sempere, Lorenzo, Beumer, Jan H., Anyang, Bean N., Nugent, William, Johnstone, David, Tsongalis, Gregory J., Kurie, Jonathan M., Li, Hua, DiRenzo, James, Guo, Yongli, Freemantle, Sarah J., Dragnev, Konstantin H., Dmitrovsky, Ethan
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3742691/
https://ncbi.nlm.nih.gov/pubmed/23686769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-12-0933
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados